Robert Kerlan, MD

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Robert Kerlan, MD

Professor, Department of Radiology, UCSF

Phone: (415) 353-1300 (appts)
Box 0628, UCSF
San Francisco, CA 94143-0628

View on UCSF Profiles

Research Summary

Robert K. Kerlan Jr., MD, FSIR, is a Professor of Clinical Radiology, Chief of Interventional Radiology at UCSF Mt. Zion Medical Center, and Chief of Interventional Radiology at UCSF. Dr. Kerlan received his medical degree from the University of Southern California in 1978, and completed his residency in Diagnostic Radiology from UCSF in 1980, followed by a Chief residency from UCSF in 1981

Dr. Kerlan's primary research interest includes the management of liver disease including biliary disease, portal hypertension, and hepatic malignancy. He has an interest in developing innovative procedures to diagnose and treat patients with problems related to liver donor transplantation. Dr. Kerlan has also been closely involved with the development of stent grafts to prolong the durability procedure of transjugular intrahepatic portosystemic shunts (TIPS). He and his colleagues have developed a number of innovative techniques to perform TIPS in patients with occluded hepatic veins.

Dr. Kerlan is a Distinguished Reviewer for the Journal of Vascular and Interventional Radiology, the American Journal of Transplantation, and Cardiovascular and Interventional Radiology. He has 202 published articles and he has written 20 book chapters, 3 books, and 5 significant publications.

Expertise:

Interventional Radiology

Specialty:

Management of liver disease including biliary disease, portal hypertension, and hepatic malignancy

Professional Interests:

Interventional radiology, liver and bile ducts, hepatocellular carcinoma, chemoembolization, ablation

Education and Training:

• Medical School: University of Southern California, Los Angeles

• Internship: University of California, Los Angeles - Internal Medicine

• Residency: University of California, San Francisco - Radiology

• Fellowship: University of California, San Francisco - Chief Resident, Radiology

• California Medical License

• Diplomate of the National Board of Medical Examiners

• Diplomate of the American Board of Radiology

• Diplomate of the American Board of Radiology with added

• Qualifications in Vascular and Interventional Radiology

• ABR Maintenance of Competence in Vascular and Interventional Radiology

Selected Publications

  1. Conrad MB, Ishaque BM, Surman AM, Kerlan RK, Hope MD, Dickey MA, Hetts SW, Wilson MW. Intraprocedural Safety and Technical Success of the MVP Micro Vascular Plug for Embolization of Pulmonary Arteriovenous Malformations. J Vasc Interv Radiol. 2015 Nov; 26(11):1735-9.
    View on PubMed
  2. Pasternak JD, Epelboym I, Seiser N, Wingo M, Herman M, Cowan V, Gosnell JE, Shen WT, Kerlan RK, Lee JA, Duh QY, Suh I. Diagnostic utility of data from adrenal venous sampling for primary aldosteronism despite failed cannulation of the right adrenal vein. Surgery. 2016 Jan; 159(1):267-74.
    View on PubMed
  3. Fidelman N, Kerlan RK. Transarterial Chemoembolization and (90)Y Radioembolization for Hepatocellular Carcinoma: Review of Current Applications Beyond Intermediate-Stage Disease. AJR Am J Roentgenol. 2015 Oct; 205(4):742-52.
    View on PubMed
  4. Olorunsola OG, Kohi MP, Behr SC, Kolli PK, Taylor AG, Tong RT, LaBerge JM, Kerlan RK, Fidelman N. Imaging Predictors of Elevated Lung Shunt Fraction in Patients Being Considered for Yttrium-90 Radioembolization. J Vasc Interv Radiol. 2015 Oct; 26(10):1472-8.
    View on PubMed
  5. Kohlbrenner R, Kolli KP, Taylor AG, Kohi MP, Fidelman N, LaBerge JM, Kerlan RK, Agarwal VK, Lehrman ED, Nanavati S, Avrin DE, Gould R. Patient Radiation Dose Reduction during Transarterial Chemoembolization Using a Novel X-Ray Imaging Platform. J Vasc Interv Radiol. 2015 Sep; 26(9):1331-8.
    View on PubMed
  6. Kohi MP, Taylor AG, Kolli KP, Fidelman N, Kerlan RK. Crossed legs: an unexpected occurrence during an ALN filter placement. Clin Imaging. 2015 Nov-Dec; 39(6):1128-9.
    View on PubMed
  7. Young K, Fidelman N, Yao FY, Hills NK, Kohi MP, Kolli KP, Taylor AG, Kerlan RK. Implications of discordant findings between hepatic angiography and cross-sectional imaging in transplant candidates with hepatocellular carcinoma. Liver Transpl. 2015 Apr; 21(4):454-67.
    View on PubMed
  8. Bartolome B, Kohi MP, Fidelman N, Taylor AG, Kolli KP, LaBerge JM, Kerlan RK. Hemothorax Resulting from Injury to the Right Inferior Phrenic Artery following Transhepatic Procedures. J Vasc Interv Radiol. 2015 Apr; 26(4):600-1.
    View on PubMed
  9. Yao FY, Mehta N, Flemming J, Dodge J, Hameed B, Fix O, Hirose R, Fidelman N, Kerlan RK, Roberts JP. Downstaging of hepatocellular cancer before liver transplant: Long-term outcome compared to tumors within Milan criteria. Hepatology. 2015 Jun; 61(6):1968-77.
    View on PubMed
  10. Kohi MP, Naeger DM, Lorenson MJ, Taylor AG, Kolli KP, Fidelman N, Kerlan RK. Hook, line, and sinker: hook wire localization of a retained suture needle in the perineum. J Vasc Interv Radiol. 2014 Sep; 25(9):1479-80.
    View on PubMed
  11. Fidelman N, Kerlan RK, Hawkins RA, Taylor AG, Kohi MP, Kolli KP, Bergsland EK, Kelley RK, Ko AH, Korn WM, McWhirter RM, Luan J, Venook AP. 90Y glass microspheres for the treatment of unresectable metastatic liver disease from chemotherapy-refractory gastrointestinal cancers: a pilot study. J Gastrointest Cancer. 2014 Jun; 45(2):168-80.
    View on PubMed
  12. Kohi MP, Agarwal VK, Naeger DM, Taylor AG, Kolli KP, Fidelman N, LaBerge JM, Kerlan RK. The inferior emissary vein: a reliable landmark for right adrenal vein sampling. Acta Radiol. 2015 Apr; 56(4):454-7.
    View on PubMed
  13. Price AJ, Fidelman N, Wilson MW, Kerlan RK. Percutaneous interventions in failing "necklace" hemodialysis grafts: long-term outcomes. J Vasc Interv Radiol. 2014 Feb; 25(2):199-205.
    View on PubMed
  14. Kuo YC, Kohi MP, Naeger DM, Tong RT, Kolli KP, Taylor AG, Laberge JM, Kerlan RK, Fidelman N. Efficacy of TACE in TIPS patients: comparison of treatment response to chemoembolization for hepatocellular carcinoma in patients with and without a transjugular intrahepatic portosystemic shunt. Cardiovasc Intervent Radiol. 2013 Oct; 36(5):1336-43.
    View on PubMed
  15. Veal DR, Lee AY, Kerlan RK, Gordon RL, Fidelman N. Outcomes of metallic biliary stent insertion in patients with malignant bilobar obstruction. J Vasc Interv Radiol. 2013 Jul; 24(7):1003-10.
    View on PubMed
  16. Kohi MP, Fidelman N, Kerlan RK. Reply to Re: Hepatotoxicity after transarterial chemoembolization and transjugular intrahepatic portosystemic shunt: do two rights make a wrong? J Vasc Interv Radiol. 2013 Jul; 24(7):1076.
    View on PubMed
  17. Olorunsola OG, Kohi MP, Fidelman N, LaBerge JM, Kerlan RK. Failure of filter reexpansion during unsuccessful retrieval of Option inferior vena cava filter. J Vasc Interv Radiol. 2013 Jul; 24(7):1065-7.
    View on PubMed
  18. Johnson DT, Durack JC, Fidelman N, Kerlan RK, LaBerge JM. Distribution of reported StarClose SE vascular closure device complications in the manufacturer and user facility device experience database. J Vasc Interv Radiol. 2013 Jul; 24(7):1051-6.
    View on PubMed
  19. Tong RT, Kohi M, Fidelman N, Kuo YC, Foster R, Peled A, Kolli KP, Taylor AG, LaBerge JM, Kerlan RK. Clinical outcomes of percutaneous drainage of breast fluid collections after mastectomy with expander-based breast reconstruction. J Vasc Interv Radiol. 2013 Sep; 24(9):1369-74.
    View on PubMed
  20. Marshall D, Laberge JM, Firetag B, Miller T, Kerlan RK. The changing face of percutaneous image-guided biopsy: molecular profiling and genomic analysis in current practice. J Vasc Interv Radiol. 2013 Aug; 24(8):1094-103.
    View on PubMed

Go to UCSF Profiles, powered by CTSI